CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,377,699
- in 4 filings, $108K under 10b5-1 plans
Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-30 | BERBERIAN LANCE EVP, CIO & CTO | Grant or award | +4,509 | 24,677 | ||
| 2023-03-30 | BERBERIAN LANCE EVP, CIO & CTO | Shares withheld for taxes | −1,799 | $224.70 | $404K | 22,878 |
| 2023-03-30 | Schroeder Mark S EVP, President-Diagnostics Lab | Grant or award 10b5-1 | +6,763 | 13,450.4 | ||
| 2023-03-30 | Schroeder Mark S EVP, President-Diagnostics Lab | Shares withheld for taxes 10b5-1 | −2,866 | $224.70 | $644K | 10,584.4 |
| 2023-03-30 | Seltz Judith C EVP, CHRO | Grant or award | +3,381 | 5,345.95 | ||
| 2023-03-30 | Seltz Judith C EVP, CHRO | Shares withheld for taxes | −1,164 | $224.70 | $262K | 4,181.95 |
| 2023-03-30 | Summy Amy B. EVP, Chief Marketing Officer | Grant or award | +3,234 | 4,903 | ||
| 2023-03-30 | Summy Amy B. EVP, Chief Marketing Officer | Shares withheld for taxes | −1,269 | $224.70 | $285K | 3,634 |
| 2023-03-30 | van der Vaart Sandra D EVP, Chief Legal Officer | Grant or award | +3,609 | 9,161.76 | ||
| 2023-03-30 | van der Vaart Sandra D EVP, Chief Legal Officer | Shares withheld for taxes | −1,371 | $224.70 | $308K | 7,790.76 |
| 2023-03-30 | Wilkinson Peter J SVP, Chief Accounting Officer | Grant or award | +1,798 | 3,958.22 | ||
| 2023-03-30 | Wilkinson Peter J SVP, Chief Accounting Officer | Shares withheld for taxes | −526 | $224.70 | $118K | 3,432.22 |
| 2023-03-02 | Summy Amy B. EVP, Chief Marketing Officer | Exercise or conversion | +1,340 | 2,043 | ||
| 2023-03-02 | Summy Amy B. EVP, Chief Marketing Officer | Shares withheld for taxes | −374 | $239.46 | $90K | 1,669 |
| 2023-03-02 | Summy Amy B. EVP, Chief Marketing Officer | Exercise or conversion · Restricted Stock Unit | −1,340 | 1,180 | ||
| 2023-02-21 | Kirchgraber Paul R CEO, Covance Drug Development | Exercise or conversion | +3,000 | $182.51 | $548K | 17,069 |
| 2023-02-21 | Kirchgraber Paul R CEO, Covance Drug Development | Sale | −8,000 | $250.58 | $2.0M | 9,069 |
| 2023-02-21 | Kirchgraber Paul R CEO, Covance Drug Development | Exercise or conversion · Non-qualified Stock Options | −3,000 | 4,300 | ||
| 2023-02-14 | Schroeder Mark S EVP, President-Diagnostics Lab | Sale | −309 | $247.63 | $77K | 6,687.4 |
| 2023-02-13 | BELINGARD JEAN-LUC Director | Shares withheld for taxes | −75 | $248.13 | $19K | 16,929 |
Page 38 of 41 · 816 trades